抗肺结核药物研究进展

Structureactivity relationship of the quinolone antibacterials against mycobacteria: effect of structural changes at N -1 and C-7. Renau TE,Sanchez JP,Gage JW,et al. Journal of Medicinal Chemistry . 1996

Structure activity relationship of the quinolone agents against mycobacteria: effect of structural modifications at the 8 position. Renau TE,Gage JW,Dever JA,et al. Antimicrobial Agents and Chemotherapy . 1996

I n vivo efficacy of ABT-255 against drug-sensitive and drugresistant Mycobacterium tuberculosis strains. Olekssijew A,Meulbroek J,Ewing P,et al. Antimicrobial Agents and Chemotherapy . 1998

I n vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. Ji BH,Lounis N,Maslo c,et al. Antimicrobial Agents and Chemotherapy . 1998

DRUGS[P]. HIDAKA HIROYOSHI;TAKAGI MANABU;MATSUZAKI TAKUSHI.WO9964011A1,1999-12-16

Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tomioka H,Sato K,Kajitani H,et al. Antimicrobial Agents and Chemotherapy . 2000

Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a ),gatifloxacin ( AM-1155 ), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tomioka H,Sato K,Kajitani H,et al. Antimicrobial Agents and Chemotherapy . 1999

I n vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first -line antituberculosis drugs. Ruiz -Serrano MJ,Alcala L,Martinez L,et al. Antimicrobial Agents and Chemotherapy . 2000

Mechanisms of latency in mycobacterium tuberculosis. Parrish NM,Dick JD,Bishai WR. Trends in Microbiology . 1998

Antimycobacterial activities of 2, 4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase. Suling WJ,Seitz LE,Pathak V,et al. Antimicrobial Agents and Chemotherapy . 2000

Structureactivity relationship of the quinolone antibacterials against mycobacteria: effect of structural changes at N -1 and C-7. Renau TE,Sanchez JP,Gage JW,et al. Journal of Medicinal Chemistry . 1996

Structure activity relationship of the quinolone agents against mycobacteria: effect of structural modifications at the 8 position. Renau TE,Gage JW,Dever JA,et al. Antimicrobial Agents and Chemotherapy . 1996

I n vivo efficacy of ABT-255 against drug-sensitive and drugresistant Mycobacterium tuberculosis strains. Olekssijew A,Meulbroek J,Ewing P,et al. Antimicrobial Agents and Chemotherapy . 1998

I n vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. Ji BH,Lounis N,Maslo c,et al. Antimicrobial Agents and Chemotherapy . 1998

DRUGS[P]. HIDAKA HIROYOSHI;TAKAGI MANABU;MATSUZAKI TAKUSHI.WO9964011A1,1999-12-16

Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tomioka H,Sato K,Kajitani H,et al. Antimicrobial Agents and Chemotherapy . 2000

Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a ),gatifloxacin ( AM-1155 ), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tomioka H,Sato K,Kajitani H,et al. Antimicrobial Agents and Chemotherapy . 1999

I n vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first -line antituberculosis drugs. Ruiz -Serrano MJ,Alcala L,Martinez L,et al. Antimicrobial Agents and Chemotherapy . 2000

Mechanisms of latency in mycobacterium tuberculosis. Parrish NM,Dick JD,Bishai WR. Trends in Microbiology . 1998

Antimycobacterial activities of 2, 4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase. Suling WJ,Seitz LE,Pathak V,et al. Antimicrobial Agents and Chemotherapy . 2000